Almac Group Ltd - Company Profile
Powered by 
All the data and insights you need on Almac Group Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Almac Group Ltd Strategy Report
- Understand Almac Group Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Almac Group Catalyst Calendar
Proactively evaluate Almac Group Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Almac Group Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 23 Oct 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 Oct 2019 | Phase II Trial Initiation | Allucent; Almac Group Ltd; Hengyi Biomedical Technology (Shanghai) Co Ltd; Leading BioSciences Inc; Newsoara Biopharma Co Ltd; Palisade Bio, Inc | PALI | tranexamic acid | Gastrointestinal | Ileus (Intestinal Obstruction); Postoperative Ileus | Clinical Trial Registry |
| 30 Sep 2019 | Phase III Trial Results | Almac Group Ltd; Johnson & Johnson; Quotient Sciences Ltd | JNJ | abiraterone acetate | Oncology | Castration-Resistant Prostate Cancer (CRPC); Metastatic Castration-Resistant Prostate Cancer (mCRPC); Metastatic Prostate Cancer; Prostate Cancer | Company Press Release |
| 23 Aug 2019 | Phase III Trial Initiation | Almac Group Ltd; Celgene Corp; Impact Biomedicines Inc; Xinji Pharmaceutical Consulting (Shanghai) Co Ltd | - | fedratinib | Oncology | Myelofibrosis; Polycythemia Vera; Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF); Post-Polycythemia Vera Myelofibrosis (PPV-MF) | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer